Highlights in pathogenic fungal biofilms

Revista Iberoamericana de Micologia

Volumn 31, Issue 1, 2014, Pages 22-29

  Sardi, Janaina De Cássia Orlandi ^a   Pitangui, Nayla De Souza ^a   Rodríguez Arellanes, Gabriela ^b   Taylor, Maria Lucia ^b   Fusco Almeida, Ana Maria ^a   Mendes Giannini, Maria José Soares ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Adhesins; Anti biofilm therapy; Biofilm; Pathogenic fungi; Quorum sensing

Indexed keywords

ADHESINAS; ADHESINS; ANTI-BIOFILM THERAPY; BIOFILM; BIOPELÍCULAS; PATHOGENIC FUNGI; PATÓGENOS FÚNGICOS; QUORUM SENSING; TRATAMIENTO ANTI-BIOPELÍCULAS;

ANTIFUNGAL AGENTS; BIOFILMS; CELL ADHESION; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; FUNGI; HUMANS; MEMBRANE PROTEINS; MYCOSES; PROTEOMICS; QUORUM SENSING; VIRULENCE;

EID: 84893775160     PISSN: 11301406     EISSN: 21739188     Source Type: Journal    
DOI: 10.1016/j.riam.2013.09.014     Document Type: Short Survey

References (140)

1. Aidé M.A. Histoplasmosis. J Bras Pneumol 2009, 35:1145-1151.
2. Albuquerque P., Casadevall A. Quorum sensing in fungi: a review. Med Mycol 2012, 50:337-345.
3. Andreotti P.F., Monteiro da Silva J.L., Bailão A.M., Soares C.M., Benard G., Soares C.P., et al. Isolation and partial characterization of a 30kDa adhesin from Paracoccidioides brasiliensis. Microbes Infect 2005, 7:875-881.
4. Arantes T.D., Theodoro R.C., Da Graça Macoris S.A., Bagagli E. Detection of Paracoccidioides spp. in environmental aerosol samples. Med Mycol 2013, 51:83-92.
5. Ashbee H.R., Leck A.K., Puntis J.W., Parsons W.J., Evans E.G. Skin colonization by Malassezia in neonates and infants. Infect Control Hosp Epidemiol 2002, 23:212-216.
6. Banerjee M., Uppuluri P., Zhao X.R., Carlisle P.L., Vipulanandan G., Villar C.C., et al. Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms. Eukaryot Cell 2013, 12:224-232.
7. Behrends V., Ryall B., Zlosnik J.E., Speert D.P., Bundy J.G., Williams H.D. Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ Microbiol 2013, 15:398-408.
8. Biasoli M.S., Tosello M.E., Magaró H.M. Adherence of Candida strains isolated from the human gastrointestinal tract. Mycoses 2002, 45:465-469.
9. Bink A., Vandenbosch D., Coenye T., Nelis H., Cammue B.P., Thevissen K. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob Agents Chemother 2011, 55:4033-4037.
10. Boletti F.T. Manufactor of vinegar. Microbiology: a textbook on microorganisms general and applied 1921, CE Marshall.
11. Cafarchia C., Otranto D. The pathogenesis of Malassezia yeasts. Parassitologia 2008, 50:65-67.
12. Canabarro A., Valle C., Farias M.R., Santos F.B., Lazera M., Wanke B. Association of subgingival colonization of Candida albicans and other yeasts with severity of chronic periodontitis. J Periodontal Res 2012, 48:428-432.
13. Cannizzo F.T., Eraso E., Ezkurra P.A., Villar-Vidal M., Bollo E., Castellá G., et al. Biofilm development by clinical isolates of Malassezia pachydermatis. Med Mycol 2007, 45:357-361.
14. Ceri H., Olson M., Morck D., Storey D., Read R., Buret A., et al. The MBEC Assay System: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol 2001, 337:377-385.
15. Chen C.M., Lee J.A., Huang T.C. Construction of a light-emitting diode fluorescence detector for high-performance liquid chromatography and its application to fluorometric determination of L-3-hydroxybutyrate. Biomed Chromatogr 2012, 26:256-260.
16. Chen H., Fink G.R. Feedback control of morphogenesis in fungi by aromatic alcohols. Genes Dev 2006, 20:1150-1161.
17. Chen H., Fujita M., Feng Q., Clardy J., Fink G.R. Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci U S A 2004, 101:5048-5052.
18. Chryssanthou E., Broberger U., Petrini B. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr 2001, 90:323-327.
19. Cos P., Toté K., Horemans T., Maes L. Biofilms: an extra hurdle for effective antimicrobial therapy. Curr Pharm Des 2010, 16:2279-2295.
20. Costerton J.W., Geesey G.G., Cheng K.J. How bacteria stick. Sci Am 1978, 238:86-95.
21. Costerton J.W., Lewandowski Z., Caldwell D.E., Korber D.R., Lappin-Scott H.M. Microbial biofilms. Annu Rev Microbiol 1995, 49:711-745.
22. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
23. Cuéllar-Cruz M., López-Romero E., Villagómez-Castro J.C., Ruiz-Baca E. Candida species: new insights into biofilm formation. Future Microbiol 2012, 7:755-771.
24. Curvale-Fauchet N., Botterel F., Legrand P., Guillot J., Bretagne S. Frequency of intravascular catheter colonization by Malassezia spp. in adult patients. Mycoses 2004, 47:491-494.
25. Cushion M.T., Collins M.S., Linke M.J. Biofilm formation by Pneumocystis spp. Eukaryot Cell 2009, 8:197-206.
26. D'Antonio D., Parruti G., Pontieri E., Di Bonaventura G., Manzoli L., Sferra R., et al. Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheter-related fungemia. Eur J Clin Microbiol Infect Dis 2004, 23:787-789.
27. da Silva Neto B.R., de Fátima da Silva J., Mendes-Giannini M.J., Lenzi H.L., de Almeida Soares C.M., Pereira M. The malate synthase of Paracoccidioides brasiliensis is a linked surface protein that behaves as an anchorless adhesin. BMC Microbiol 2009, 9:272.
28. Davis L.E., Cook G., Costerton J.W. Biofilm on ventriculo-peritoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis. Emerg Infect Dis 2002, 8:376-379.
29. De Almeida G.M., Costa S.F., Melhem M., Motta A.L., Szeszs M.W., Miyashita F., et al. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med Mycol 2008, 46:547-556.
30. Derengowski L.S., De-Souza-Silva C., Braz S.V., Mello-De-Sousa T.M., Báo S.N., Kyaw C.M., et al. Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann Clin Microbiol Antimicrob 2009, 8:13.
31. Di Bonaventura G., Pompilio A., Picciani C., Iezzi M., D'Antonio D., Piccolomini R. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother 2006, 50:3269-3276.
32. Donlan R.M. Biofilms and device-associated infections. Emerg Infect Dis 2001, 7:277-281.
33. Donofrio F.C., Calil A.C., Miranda E.T., Almeida A.M., Benard G., Soares C.P., et al. Enolase from Paracoccidioides brasiliensis: isolation and identification as a fibronectin-binding protein. J Med Microbiol 2009, 58:706-713.
34. Edwards S., Kjellerup B.V. Exploring the applications of invertebrate host-pathogen models for in vivo biofilm infections. FEMS Immunol Med Microbiol 2012, 65:205-214.
35. Escande W., Fayad G., Modine T., Verbrugge E., Koussa M., Senneville E., et al. Culture of a prosthetic valve excised for streptococcal endocarditis positive for Aspergillus fumigatus 20 years after previous A fumigatus endocarditis. Ann Thorac Surg 2011, 91:e92-e93.
36. Ewbank J.J., Zugasti O. C. elegans: model host and tool for antimicrobial drug discovery. Dis Model Mech 2011, 4:300-304.
37. Figueredo L.A., Cafarchia C., Desantis S., Otranto D. Biofilm formation of Malassezia pachydermatis from dogs. Vet Microbiol 2012, 160:126-131.
38. Filler S.G. Candida-host cell receptor-ligand interactions. Curr Opin Microbiol 2006, 9:333-339.
39. Filler S.G., Sheppard D.C. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2006, 2:e129.
40. Finkel J.S., Mitchell A.P. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 2011, 9:109-118.
41. Fox E.P., Nobile C.J. A sticky situation: untangling the transcriptional network controlling biofilm development in Candida albicans. Transcription 2012, 3:315-322.
42. García-Contreras R., Argueta-Figueroa L., Mejía-Rubalcava C., Jiménez-Martínez R., Cuevas-Guajardo S., Sánchez-Reyna P.A., et al. Perspectives for the use of silver nanoparticles in dental practice. Int Dent J 2011, 61:297-301.
43. Garsin D.A., Willems R.J. Insights into the biofilm lifestyle of enterococci. Virulence 2010, 1:219-221.
44. Gomase V.S., Kale K.V., Tagore S., Hatture S.R. Proteomics: technologies for protein analysis. Curr Drug Metab 2008, 9:213-220.
45. Gullo F.P., Sardi J.C., Santos V.A., Sangalli-Leite F., Pitangui N.S., Rossi S.A., et al. Antifungal activity of maytenin and pristimerin. Evid Based Complement Alternat Med 2012, 2012:3407-3487.
46. Gupta R.K., Chhibber S., Harjai K. Quorum sensing signal molecules cause renal tissue inflammation through local cytokine responses in experimental UTI caused by Pseudomonas aeruginosa. Immunobiology 2013, 218:181-185.
47. Hanna S.A., Monteiro da Silva J.L., Giannini M.J. Adherence and intracellular parasitism of Paracoccidioides brasiliensis in Vero cells. Microbes Infect 2000, 2:877-884.
48. Hense B.A., Kuttler C., Müller J., Rothballer M., Hartmann A., Kreft J.U. Does efficiency sensing unify diffusion and quorum sensing?. Nat Rev Microbiol 2007, 5:230-239.
49. Hernández O., Almeida A.J., Tamayo D., Torres I., Garcia A.M., López A., et al. The hydrolase PbHAD32 participates in the adherence of Paracoccidioides brasiliensis conidia to epithelial lung cells. Med Mycol 2012, 50:533-537.
50. Hogan D.A. Talking to themselves: autoregulation and quorum sensing in fungi. Eukaryot Cell 2006, 5:613-619.
51. Hogan L.H., Klein B.S., Levitz S.M. Virulence factors of medically important fungi. Clin Microbiol Rev 1996, 9:469-488.
52. Horré R., Symoens F., Delhaes L., Bouchara J.P. Fungal respiratory infections in cystic fibrosis: a growing problem. Med Mycol 2010, 48:S1-S3.
53. Hoyer L.L., Green C.B., Oh S.H., Zhao X. Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family-a sticky pursuit. Med Mycol 2008, 46:1-15.
54. Hoyer L.L., Payne T.L., Hecht J.E. Identification of Candida albicans ALS2 and ALS4 and localization of als proteins to the fungal cell surface. J Bacteriol 1998, 180:5334-5343.
55. Hoyer L.L., Scherer S., Shatzman A.R., Livi G.P. Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol Microbiol 1995, 15:39-54.
56. Huhn G.D., Austin C., Carr M., Heyer D., Boudreau P., Gilbert G., et al. Two outbreaks of occupationally acquired histoplasmosis: more than workers at risk. Environ Health Perspect 2005, 113:585-589.
57. Jabra-Rizk M.A., Falkler W.A., Meiller T.F. Fungal biofilms and drug resistance. Emerg Infect Dis 2004, 10:14-19.
58. Jabra-Rizk M.A., Shirtliff M., James C., Meiller T. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. FEMS Yeast Res 2006, 6:1063-1073.
59. Jass J., O'Neill J.G., Walker J.T. Direct biofilm monitoring by a capacitance measurement probe in continuous culture chemostats. Methods Enzymol 2001, 337:63-70.
60. Jayshree R.S., Shafiulla M., George J., David J.K., Bapsy P.P., Chakrabarti A. Microscopic, cultural and molecular evidence of disseminated invasive aspergillosis involving the lungs and the gastrointestinal tract. J Med Microbiol 2006, 55:961-964.
61. Jeloka T.K., Shrividya S., Wagholikar G. Catheter outflow obstruction due to an aspergilloma. Perit Dial Int 2011, 31:211-212.
62. Junqueira J.C., Jorge A.O., Barbosa J.O., Rossoni R.D., Vilela S.F., Costa A.C., et al. Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc). Lasers Med Sci 2012, 27:1205-1212.
63. Kojic E.M., Darouiche R.O. Candida infections of medical devices. Clin Microbiol Rev 2004, 17:255-267.
64. Kucharíková S., Tournu H., Lagrou K., Van Dijck P., Bujdáková H. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol 2011, 60:1261-1269.
65. LaFleur M.D., Kumamoto C.A., Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006, 50:3839-3846.
66. Lebeaux D., Ghigo J.M. Management of biofilm-associated infections: what can we expect from recent research on biofilm lifestyles?. Med Sci (Paris) 2012, 28:727-739.
67. Lee S.W. An aspergilloma mistaken for a pelviureteral stone on nonenhanced CT: a fungal bezoar causing ureteral obstruction. Korean J Urol 2010, 51:216-218.
68. Lewis K. Persister cells: molecular mechanisms related to antibiotic tolerance. Handb Exp Pharmacol 2012, 211:121-133.
69. López-Villar E., Monteoliva L., Larsen M.R., Sachon E., Shabaz M., Pardo M., et al. Genetic and proteomic evidences support the localization of yeast enolase in the cell surface. Proteomics 2006, 6:S107-S118.
70. Lu X., Zhang B., Wang Y., Zhou X., Weng J., Qu S., et al. Nano-Ag-loaded hydroxyapatite coatings on titanium surfaces by electrochemical deposition. J R Soc Interface 2011, 8:529-539.
71. Marcos C.M., de Fátima da Silva J., de Oliveira H.C., Moraes da Silva R.A., Mendes-Giannini M.J., Fusco-Almeida A.M. Surface-expressed enolase contributes to the adhesion of Paracoccidioides brasiliensis to host cells. FEMS Yeast Res 2012, 12:557-570.
72. Marques-da-Silva S.H., Rodrigues A.M., de Hoog G.S., Silveira-Gomes F., Camargo Z.P. Occurrence of Paracoccidioides lutzii in the Amazon region: description of two cases. Am J Trop Med Hyg 2012, 87:710-714.
73. Martínez-Gomariz M., Perumal P., Mekala S., Nombela C., Chaffin W.L., Gil C. Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans. Proteomics 2009, 9:2230-2252.
74. Martinez L.R., Bryan R.A., Apostolidis C., Morgenstern A., Casadevall A., Dadachova E. Antibody-guided alpha radiation effectively damages fungal biofilms. Antimicrob Agents Chemother 2006, 50:2132-2136.
75. Martinez L.R., Casadevall A. Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Appl Environ Microbiol 2007, 73:4592-4601.
76. Martinez L.R., Casadevall A. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 2005, 73:6350-6362.
77. Martinez L.R., Christaki E., Casadevall A. Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro. J Infect Dis 2006, 194:261-266.
78. Martinez L.R., Fries B.C. Fungal biofilms: relevance in the setting of human disease. Curr Fungal Infect Rep 2010, 4:266-275.
79. Martinez-Pajares J.D., Martinez-Ferriz M.C., Moreno-Perez D., Garcia-Ramirez M., Martin-Carballido S., Blanch-Iribarne P. Management of obstructive renal failure caused by bilateral renal aspergilloma in an immunocompetent newborn. J Med Microbiol 2010, 59:367-369.
80. McCoy W.F., Bryers J.D., Robbins J., Costerton J.W. Observations of fouling biofilm formation. Can J Microbiol 1981, 27:910-917.
81. McMahon J.P., Wheat J., Sobel M.E., Pasula R., Downing J.F., Martin W.J. Murine laminin binds to Histoplasma capsulatum. A possible mechanism of dissemination. J Clin Invest 1995, 96:1010-1017.
82. Mendes-Giannini M.J., Andreotti P.F., Vincenzi L.R., da Silva J.L., Lenzi H.L., Benard G., et al. Binding of extracellular matrix proteins to Paracoccidioides brasiliensis. Microbes Infect 2006, 8:1550-1559.
83. Mendes-Giannini M.J., Monteiro da Silva J.L., de Fátima da Silva J., Donofrio F.C., Miranda E.T., Andreotti P.F., et al. Interactions of Paracoccidioides brasiliensis with host cells: recent advances. Mycopathologia 2008, 165:237-248.
84. Mendes-Giannini M.J., Soares C.P., da Silva J.L., Andreotti P.F. Interaction of pathogenic fungi with host cells: molecular and cellular approaches. FEMS Immunol Med Microbiol 2005, 45:383-394.
85. Miller M.B., Bassler B.L. Quorum sensing in bacteria. Annu Rev Microbiol 2001, 55:165-199.
86. Moss R.B. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. Curr Opin Pulm Med 2010, 16:598-603.
87. Mowat E., Butcher J., Lang S., Williams C., Ramage G. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol 2007, 56:1205-1212.
88. Mowat E., Williams C., Jones B., McChlery S., Ramage G. The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?. Med Mycol 2009, 47:S120-S126.
89. Müller F.M., Seidler M., Beauvais A. Aspergillus fumigatus biofilms in the clinical setting. Med Mycol 2011, 49:S96-S100.
90. Nailis H., Coenye T., Van Nieuwerburgh F., Deforce D., Nelis H.J. Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol 2006, 7:25.
91. Nam K.Y. In vitro antimicrobial effect of the tissue conditioner containing silver nanoparticles. J Adv Prosthodont 2011, 3:20-24.
92. Nobile C.J., Schneider H.A., Nett J.E., Sheppard D.C., Filler S.G., Andes D.R., et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol 2008, 18:1017-1024.
93. Nosanchuk J.D., Zancopé-Oliveira R.M., Hamilton A.J., Guimarães A.J. Antibody therapy for histoplasmosis. Front Microbiol 2012, 3. 10.3389/fmicb.2012.00021.
94. Nunes J.M., Bizerra F.C., Ferreira R.C., Colombo A.L. Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates. Antimicrob Agents Chemother 2013, 57:382-389.
95. O'Connor L., Lahiff S., Casey F., Glennon M., Cormican M., Maher M. Quantification of ALS1 gene expression in Candida albicans biofilms by RT-PCR using hybridisation probes on the LightCycler. Mol Cell Probes 2005, 19:153-162.
96. Okita W.B., Kirwan D.J. Simulation of secondary metabolite production by immobilized living cells: penicillin production. Biotechnol Prog 1986, 2:83-90.
97. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001, 58:902-920.
98. Parsek M.R., Fuqua C. Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life. J Bacteriol 2004, 186:4427-4440.
99. Pitangui N.S., Sardi J.C., Silva J.F., Benaducci T., Moraes da Silva R.A., Rodríguez-Arellanes G., et al. Adhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface. Biofouling 2012, 28:711-718.
100. Pires R.H., da Silva J.D., Martins C.H., Fusco Almeida A.M., Soares C.P., Mendes-Giannini M.J. Effectiveness of disinfectants used in hemodialysis against both Candida orthopsilosis and C. parapsilosis sensu stricto biofilms. Antimicrob Agents Chemother 2013, 57:2417-2421.
101. Pires R.H., Lucarini R., Mendes-Giannini M.J. Effect of usnic acid on Candida orthopsilosis and C. parapsilosis. Antimicrob Agents Chemother 2012, 56:595-597.
102. Pires R.H., Montanari L.B., Martins C.H., Zaia J.E., Almeida A.M., Matsumoto M.T., et al. Anticandidal efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis. Mycopathologia 2011, 172:453-464.
103. Puskas A., Greenberg E.P., Kaplan S., Schaefer A.L. A quorum-sensing system in the free-living photosynthetic bacterium Rhodobacter sphaeroides. J Bacteriol 1997, 179:7530-7537.
104. Ramage G., Mowat E., Jones B., Williams C., Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol 2009, 35:340-355.
105. Ramage G., Rajendran R., Gutierrez-Correa M., Jones B., Williams C. Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol Lett 2011, 324:89-97.
106. Ramage G., Rajendran R., Sherry L., Williams C. Fungal biofilm resistance. Int J Microbiol 2012, 10.1155/2012/528521.
107. Ramage G., Saville S.P., Thomas D.P., López-Ribot J.L. Candida biofilms: an update. Eukaryot Cell 2005, 4:633-638.
108. Ramage G., Saville S.P., Wickes B.L., López-Ribot J.L. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002, 68:5459-5463.
109. Rawlings D.E., Dew D., du Plessis C. Biomineralization of metal-containing ores and concentrates. Trends Biotechnol 2003, 21:38-44.
110. Reynolds T.B., Fink G.R. Bakers' yeast, a model for fungal biofilm formation. Science 2001, 291:878-881.
111. Ribeiro D.S., Frigerio C., Santos J.L., Prior J.A. Photoactivation by visible light of CdTe quantum dots for inline generation of reactive oxygen species in an automated multipumping flow system. Anal Chim Acta 2012, 735:69-75.
112. Rohde H., Frankenberger S., Zähringer U., Mack D. Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur J Cell Biol 2010, 89:103-111.
113. Römling U., Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 2012, 272:541-561.
114. Sakurai A., Imai H., Takenaka Y., Sakakibara M. Simulation of citric acid production by rotating disk contactor. Biotechnol Bioeng 1997, 56:689-696.
115. Sardi J.C., Scorzoni L., Bernardi T., Fusco-Almeida A.M., Mendes Giannini M.J. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013, 62:10-24.
116. Savini V., Sozio F., Catavitello C., Talia M., Manna A., Febbo F., et al. Femoral prosthesis infection by Rhodotorula mucilaginosa. J Clin Microbiol 2008, 46:3544-3545.
117. Semighini C.P., Hornby J.M., Dumitru R., Nickerson K.W., Harris S.D. Farnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi. Mol Microbiol 2006, 59:753-764.
118. Seneviratne C.J., Wang Y., Jin L., Abiko Y., Samaranayake L.P. Candida albicans biofilm formation is associated with increased anti-oxidative capacities. Proteomics 2008, 8:2936-2947.
119. Sharma M., Prasad R. The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans. Antimicrob Agents Chemother 2011, 55:4834-4843.
120. Shirtliff M.E., Krom B.P., Meijering R.A., Peters B.M., Zhu J., Scheper M.A., et al. Farnesol-induced apoptosis in Candida albicans. Antimicrob Agents Chemother 2009, 53:2392-2401.
121. Singh A., Del Poeta M. Lipid signalling in pathogenic fungi. Cell Microbiol 2011, 13:177-185.
122. Singh R., Shivaprakash M.R., Chakrabarti A. Biofilm formation by zygomycetes: quantification, structure and matrix composition. Microbiology 2011, 157:2611-2618.
123. Smith J.A., Kauffman C.A. Pulmonary fungal infections. Respirology 2012, 17:913-926.
124. Suárez-Alvarez R.O., Pérez-Torres A., Taylor M.L. Adherence patterns of Histoplasma capsulatum yeasts to bat tissue sections. Mycopathologia 2010, 170:79-87.
125. Sun L.M., Zhang C.L., Li P. Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol. J Agric Food Chem 2012, 60:6150-6156.
126. Taff H.T., Nett J.E., Zarnowski R., Ross K.M., Sanchez H., Cain M.T., et al. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 2012, 8:e1002848.
127. Tagliari L., Toledo M.S., Lacerda T.G., Suzuki E., Straus A.H., Takahashi H.K. Membrane microdomain components of Histoplasma capsulatum yeast forms, and their role in alveolar macrophage infectivity. Biochim Biophys Acta 2012, 1818:458-466.
128. Taraszkiewicz A., Fila G., Grinholc M., Nakonieczna J. Innovative strategies to overcome biofilm resistance. BioMed Res Int 2013, 2013:1-13. 10.1155/2013/150653.
129. Thomas D.P., Bachmann S.P., Lopez-Ribot J.L. Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics 2006, 6:5795-5804.
130. Thevissen K., Pellens K., De Brucker K., François I.E., Chow K.K., Meert E.M., et al. Novel fungicidal benzylsulfanyl-phenylguanidines. Bioorg Med Chem Lett 2011, 21:3686-3692.
131. Tuon F.F., Costa S.F. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol 2008, 25:135-140.
132. Unal A., Koc A.N., Sipahioglu M.H., Kavuncuoglu F., Tokgoz B., Buldu H.M., et al. CAPD-related peritonitis caused by Rhodotorula mucilaginosa. Perit Dial Int 2009, 29:581-582.
133. Uppuluri P., Chaturvedi A.K., Srinivasan A., Banerjee M., Ramasubramaniam A.K., Köhler J.R., et al. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog 2010, 6:e1000828.
134. Vicentini A.P., Gesztesi J.L., Franco M.F., de Souza W., de Moraes J.Z., Travassos L.R., et al. Binding of Paracoccidioides brasiliensis to laminin through surface glycoprotein gp43 leads to enhancement of fungal pathogenesis. Infect Immun 1994, 62:1465-1469.
135. Vlamakis H. The world of biofilms. Virulence 2011, 2:431-434.
136. Walgren J.L., Thompson D.C. Application of proteomic technologies in the drug development process. Toxicol Lett 2004, 149:377-385.
137. Walsh T.J., Schlegel R., Moody M.M., Costerton J.W., Salcman M. Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery 1986, 18:373-375.
138. Williams P. Quorum sensing, communication and cross-kingdom signalling in the bacterial world. Microbiology 2007, 153:3923-3938.
139. Xavier J.B., Picioreanu C., Rani S.A., van Loosdrecht M.C., Stewart P.S. Biofilm-control strategies based on enzymic disruption of the extracellular polymeric substance matrix-a modelling study. Microbiology 2005, 151:3817-3832.
140. Zhao X., Oh S.H., Yeater K.M., Hoyer L.L. Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. Microbiology 2005, 151:1619-1630.